These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 15120736

  • 1. Differential effects of the combination of caspofungin and terbinafine against Candida albicans, Candida dubliniensis and Candida kefyr.
    Gil-Lamaignere C, Müller FM.
    Int J Antimicrob Agents; 2004 May; 23(5):520-3. PubMed ID: 15120736
    [Abstract] [Full Text] [Related]

  • 2. In vitro activity of caspofungin (MK-0991) against Candida albicans clinical isolates displaying different mechanisms of azole resistance.
    Bachmann SP, Patterson TF, López-Ribot JL.
    J Clin Microbiol; 2002 Jun; 40(6):2228-30. PubMed ID: 12037093
    [Abstract] [Full Text] [Related]

  • 3. In vitro effects of micafungin against Candida biofilms on polystyrene and central venous catheter sections.
    Seidler M, Salvenmoser S, Müller FM.
    Int J Antimicrob Agents; 2006 Dec; 28(6):568-73. PubMed ID: 17101265
    [Abstract] [Full Text] [Related]

  • 4. Emergence of a Candida krusei isolate with reduced susceptibility to caspofungin during therapy.
    Hakki M, Staab JF, Marr KA.
    Antimicrob Agents Chemother; 2006 Jul; 50(7):2522-4. PubMed ID: 16801435
    [Abstract] [Full Text] [Related]

  • 5. In vitro activity of a new pneumocandin antifungal, L-743,872, against azole-susceptible and -resistant Candida species.
    Vazquez JA, Lynch M, Boikov D, Sobel JD.
    Antimicrob Agents Chemother; 1997 Jul; 41(7):1612-4. PubMed ID: 9210698
    [Abstract] [Full Text] [Related]

  • 6. In vitro interaction of posaconazole and caspofungin against clinical isolates of Candida glabrata.
    Oliveira ER, Fothergill AW, Kirkpatrick WR, Coco BJ, Patterson TF, Redding SW.
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3544-5. PubMed ID: 16048980
    [Abstract] [Full Text] [Related]

  • 7. Caspofungin-induced in-vitro post-antifungal effect and its impact on adhesion related traits of oral Candida dubliniensis and Candida albicans isolates.
    Ellepola AN, Chandy R, Khan ZU, Samaranayake LP.
    Microbiol Immunol; 2016 Mar; 60(3):160-7. PubMed ID: 26850765
    [Abstract] [Full Text] [Related]

  • 8. Anti-metabolic activity of caspofungin against Candida albicans and Candida parapsilosis biofilms.
    Cocuaud C, Rodier MH, Daniault G, Imbert C.
    J Antimicrob Chemother; 2005 Sep; 56(3):507-12. PubMed ID: 16040622
    [Abstract] [Full Text] [Related]

  • 9. The efficiency of the benzothiazole APB, the echinocandin micafungin, and amphotericin B in fluconazole-resistant Candida albicans and Candida dubliniensis.
    Melkusová S, Bujdáková H, Volleková A, Myoken Y, Mikami Y.
    Pharmazie; 2004 Jul; 59(7):573-4. PubMed ID: 15296100
    [Abstract] [Full Text] [Related]

  • 10. In Vitro activity of terbinafine combined with caspofungin and azoles against Pythium insidiosum.
    Cavalheiro AS, Maboni G, de Azevedo MI, Argenta JS, Pereira DI, Spader TB, Alves SH, Santurio JM.
    Antimicrob Agents Chemother; 2009 May; 53(5):2136-8. PubMed ID: 19289531
    [Abstract] [Full Text] [Related]

  • 11. Caspofungin activity against clinical isolates of azole cross-resistant Candida glabrata overexpressing efflux pump genes.
    Posteraro B, Sanguinetti M, Fiori B, La Sorda M, Spanu T, Sanglard D, Fadda G.
    J Antimicrob Chemother; 2006 Aug; 58(2):458-61. PubMed ID: 16757500
    [Abstract] [Full Text] [Related]

  • 12. In vitro synergism of a water insoluble fraction of Uncaria tomentosa combined with fluconazole and terbinafine against resistant non-Candida albicans isolates.
    Moraes RC, Carvalho AR, Lana AJ, Kaiser S, Pippi B, Fuentefria AM, Ortega GG.
    Pharm Biol; 2017 Dec; 55(1):406-415. PubMed ID: 27931150
    [Abstract] [Full Text] [Related]

  • 13. Candida albicans and Candida dubliniensis respond differently to echinocandin antifungal agents in vitro.
    Jacobsen MD, Whyte JA, Odds FC.
    Antimicrob Agents Chemother; 2007 May; 51(5):1882-4. PubMed ID: 17307974
    [Abstract] [Full Text] [Related]

  • 14. Calcineurin controls drug tolerance, hyphal growth, and virulence in Candida dubliniensis.
    Chen YL, Brand A, Morrison EL, Silao FG, Bigol UG, Malbas FF, Nett JE, Andes DR, Solis NV, Filler SG, Averette A, Heitman J.
    Eukaryot Cell; 2011 Jun; 10(6):803-19. PubMed ID: 21531874
    [Abstract] [Full Text] [Related]

  • 15. Azole susceptibility and resistance in Candida dubliniensis.
    Pinjon E, Moran GP, Coleman DC, Sullivan DJ.
    Biochem Soc Trans; 2005 Nov; 33(Pt 5):1210-4. PubMed ID: 16246083
    [Abstract] [Full Text] [Related]

  • 16. In vitro susceptibilities of Candida spp. to caspofungin: four years of global surveillance.
    Pfaller MA, Boyken L, Hollis RJ, Messer SA, Tendolkar S, Diekema DJ.
    J Clin Microbiol; 2006 Mar; 44(3):760-3. PubMed ID: 16517851
    [Abstract] [Full Text] [Related]

  • 17. Activities of micafungin against 315 invasive clinical isolates of fluconazole-resistant Candida spp.
    Messer SA, Diekema DJ, Boyken L, Tendolkar S, Hollis RJ, Pfaller MA.
    J Clin Microbiol; 2006 Feb; 44(2):324-6. PubMed ID: 16455878
    [Abstract] [Full Text] [Related]

  • 18. Synergism of voriconazole and terbinafine against Candida albicans isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis.
    Weig M, Müller FM.
    Antimicrob Agents Chemother; 2001 Mar; 45(3):966-8. PubMed ID: 11181393
    [Abstract] [Full Text] [Related]

  • 19. Multiechinocandin- and multiazole-resistant Candida parapsilosis isolates serially obtained during therapy for prosthetic valve endocarditis.
    Moudgal V, Little T, Boikov D, Vazquez JA.
    Antimicrob Agents Chemother; 2005 Feb; 49(2):767-9. PubMed ID: 15673762
    [Abstract] [Full Text] [Related]

  • 20. Comparative study of disc diffusion and microdilution methods in susceptibility testing of micafungin against Candida species.
    Ramírez M, Serrano MC, Castro C, López E, Almeida C, Fernández A, Romero A, Martín-Mazuelos E.
    J Antimicrob Chemother; 2006 Oct; 58(4):861-3. PubMed ID: 16916868
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.